You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Distinguishing the States of Latency and Reactivation Is Important for Human Herpesvirus 8

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We appreciate the reply by Lebbé and Agbalika1 to our remarks on the role of human herpesvirus 8 in Kaposi sarcoma.2 However, they raise a point that might lead the lay reader to confound 2 main issues in virology, namely, latency and replication.

The article in discussion by Lebbé et al3 on Kaposi sarcoma and human herpesvirus 8 maintains that the prevalence of patients with infected cells parallels the severity of the disease. They reached this conclusion by comparing the percentage of patients with infected mononucleates in stages I to II Kaposi sarcoma (27.8%) with the percentage in stages III to IV Kaposi sarcoma (70%). We objected that there is no evidence in the literature of a correspondence between the existence of latently infected cells and the severity of the disease or the involvement of other tissues. Our opinion, which, incidentally, is shared by Carrigan,4 may have been poorly expressed . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.